Lilly Drug has certainly raised hopes of researchers and doctors by doubling the good cholesterol levels in the body to lower heart risks in future.

NICE recently rejected Avastin, a bowel cancer drug for patients in advanced stages, from the house of giant drug-maker Roche, stating the it was too expensive and cannot be used by NHS, despite the fact that the Swiss pharmaceutical company was offering Avastin to the British health watchdog at subsidized rates.